转自：新华财经 12月4日至5日，以"智聚八桂 医路同行"为主题的"2025金融赋能医疗健康产业（广西）创新会议"在广西南宁成功举办。知名医药院校专家、医疗健康产业 龙头企业、金融投资机构及东盟代表，共同探讨在科技创新与制度变革双轮驱动下，如何构建"科技创新+资本赋能+产业落地"的闭环生态，助力广西打造 面向东盟的医疗健康产业高地。 这一活动由中共广西壮族自治区党委金融委员会办公室指导，国海证券、中恒集团、国海创新资本主办，广西（上海）产业合作中心协办，融中承办。 自治区党委金融办资本市场处负责人在致辞时表示，随着政策支持体系的持续完善和"科技创新+资本赋能+产业落地"的生态构建需求凸显，广西医疗健康 产业正迎来高质量发展的关键阶段，为金融资本深度参与、共创产业新蓝海提供了广阔空间。他希望各界聚焦广西"3+3"大健康产业体系，深耕重点领域， 加速科技成果在广西转化落地，精准匹配产业需求，推动创新链、产业链、资金链深度融合，助力广西打造面向东盟重要的生物医药制造基地，共拓东盟跨 境合作空间。 国海证券党委书记、董事长王海河表示，国海证券是扎根广西、服务全国的综合性上市券商，多年来始终将支持医疗健康产业发展作为服 ...

Group 1: Conference Overview - The "2025 Financial Empowerment of the Medical Health Industry (Guangxi) Innovation Conference" was successfully held in Nanning, focusing on building a closed-loop ecosystem of "technology innovation + capital empowerment + industry landing" to support the development of the medical health industry in Guangxi towards ASEAN [1][2] - The conference gathered experts from renowned medical schools, leading enterprises in the medical health industry, financial investment institutions, and ASEAN representatives to discuss the integration of technology and capital in the health sector [1][2] Group 2: Industry Insights - The Guangxi medical health industry is entering a critical phase of high-quality development, driven by continuous policy support and the need for an integrated ecosystem [1][2] - The medical health industry in China is currently experiencing a strategic opportunity period, with Guangxi positioned as a frontier for integration with ASEAN and artificial intelligence [2] Group 3: Company Strategies - Zhongheng Group has established a "1+6" industrial ecosystem centered on pharmaceutical manufacturing, focusing on deepening local medicinal resources, revitalizing traditional brands, innovating new drugs, and expanding into ASEAN markets [3] - The company aims to enhance the modernization of Guangxi's medical health industry and contribute to the "Healthy China" strategy through collaboration across the industry chain, innovation chain, and capital chain [3] Group 4: Investment and Financial Solutions - Guohai Securities provides a comprehensive financial solution for the medical health industry, integrating investment, investment banking, research, and wealth management [2][5] - Guohai Innovation Capital has transitioned from pure financial investment to a comprehensive investment platform, managing over 21.4 billion yuan and supporting multiple enterprises in entering the capital market [5] Group 5: Research and Development - The conference featured the release of the "2025 China Innovative Drug Industry Investment Blue Book," which analyzes the development trends and investment strategies in the innovative drug sector [4] - Discussions included the application of AI technology in pharmaceutical innovation and how digital transformation can drive industry upgrades [4] Group 6: Project Showcases - Ten quality enterprises showcased their projects during the conference, aiming to facilitate capital empowerment and precise matching with investment institutions [6] - Attendees also visited Zhongheng Group's industrial park to gain insights into the real dynamics of pharmaceutical manufacturing in Guangxi [6]